Onchilles Pharma Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$25M
- Investors
-
8
Onchilles Pharma General Information
Description
Operator of a drug discovery and development company intended to build myeloid-focused cancer therapeutics. The company leverages novel neutrophil and macrophage biology to develop the next generation of immunotherapies, enabling medical professionals to treat cancer patients efficiently.
Contact Information
Website
www.onchillespharma.comCorporate Office
- 9880 Campus Point Drive
- Suite 420
- San Diego, CA 92121
- United States
Corporate Office
- 9880 Campus Point Drive
- Suite 420
- San Diego, CA 92121
- United States
Onchilles Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A1) | 07-Nov-2025 | $25M | Completed | Pre-Clinical Trials | ||
| 4. Early Stage VC (Series A) | 10-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 10-Jul-2020 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 06-Dec-2017 | $150K | Completed | Pre-Clinical Trials | ||
| 1. University Spin-Out | 08-Nov-2017 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Onchilles Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Onchilles Pharma Patents
Onchilles Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026193273-A1 | Modified porcine pancreatic elastase proteins | Pending | 12-Mar-2025 | ||
| WO-2026193077-A1 | Serine proteases for treating therapy-resistant cancers | Pending | 10-Mar-2025 | ||
| WO-2026074475-A1 | Pharmaceutical compositions comprising protein complexes of modified a2m or a2ml | Pending | 03-Oct-2024 | ||
| WO-2026039369-A1 | Oncolytic viruses for delivery of therapeutic polypeptides | Pending | 13-Aug-2024 | ||
| EP-4802273-A1 | Histone h1 levels as biomarkers for cancer therapy | Pending | 03-Nov-2023 | A61K38/486 |
Onchilles Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Onchilles Pharma Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| InVivium Capital | Venture Capital | Minority | ||
| Kennedy Lewis Investment Management | Lender/Debt Provider | Minority | ||
| Lincoln Park Capital | Asset Manager | Minority | ||
| The University of Chicago Office of Investments | Limited Partner | Minority | ||
| UCM Ventures | Venture Capital | Minority |
Onchilles Pharma FAQs
-
When was Onchilles Pharma founded?
Onchilles Pharma was founded in 2017.
-
Where is Onchilles Pharma headquartered?
Onchilles Pharma is headquartered in San Diego, CA.
-
What is the size of Onchilles Pharma?
Onchilles Pharma has 9 total employees.
-
What industry is Onchilles Pharma in?
Onchilles Pharma’s primary industry is Drug Discovery.
-
Is Onchilles Pharma a private or public company?
Onchilles Pharma is a Private company.
-
What is Onchilles Pharma’s current revenue?
The current revenue for Onchilles Pharma is .
-
How much funding has Onchilles Pharma raised over time?
Onchilles Pharma has raised $35.6M.
-
Who are Onchilles Pharma’s investors?
InVivium Capital, Kennedy Lewis Investment Management, Lincoln Park Capital, The University of Chicago Office of Investments, and UCM Ventures are 5 of 8 investors who have invested in Onchilles Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
